1. Decreased oral Epstein‐Barr virus DNA loads in patients with nasopharyngeal carcinoma in Southern China: A case‐control and a family‐based study
   Wen‐Qiong Xue et al, 2018, Cancer Medicine CrossRef
2. Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma
   Sarah Renaud et al, 2020, International Journal of Molecular Sciences CrossRef
3. CMV and EBV targets recognized by tumor-infiltrating B lymphocytes in pancreatic cancer and brain tumors
   Qingda Meng et al, 2018, Scientific Reports CrossRef
4. The identification of key genes in nasopharyngeal carcinoma by bioinformatics analysis of high-throughput data
   Yanshan Ge et al, 2019, Molecular Biology Reports CrossRef
5. Epstein–Barr virus infection, B‐cell dysfunction and other risk factors converge in gut‐associated lymphoid tissue to drive the immunopathogenesis of multiple sclerosis: a hypothesis
   Jonatan Leffler et al, 2022, Clinical & Translational Immunology CrossRef